trial
as of 2026-07-01Investigating the Effect of a Single-dose of Levetiracetam on Brain Function, Chemistry and Cognitive Performance in Psychosis Risk
NCTId NCT06224530
at a glance
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Recruiting
Enrollment
69 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Quadruple
Start
2024-07-19
Primary completion
2026-02
Eligibility
ALL · 18 Years · 40 Years
Interventions & indications
Drugs
Indications
Sponsors
King's College LondonLead Sponsor
Investigators
1
Gemma Modinos, BSc MSc PhDPrincipal Investigator
Sites
1 total
London, United Kingdom
Facts & assertions
4 sourced
Enrollment
69
Phase
NA
Primary Completion Date
2026-02
Status
RECRUITING
relationships
The graph out of here
drug
drug
lead_sponsor
company
indication
indication
indication
investigator